Clinical Outsourcing Katalyst CRO offers end-to-end clinical research and regulatory services across pre-clinical to Phase IV, presenting opportunities to partner on full lifecycle development for pharma, biotech, and medical device clients seeking to outsource non-core functions.

Regulatory & Quality With strong cGxP, GMP, GLP, and GCP capabilities, there are sales openings to support clients needing regulatory affairs, validations, and quality systems to accelerate submissions and ensure compliance across global markets.

Lifecycle Expansion The company’s advisory-build-operate model enables clients to de-risk programs; this can be leveraged to upsell additional services such as data management, biostatistics, pharmacovigilance, and post-market surveillance for ongoing programs.

Tech Enablement Existing tech stack including AWS, Power BI, SAP, Jira, Boomi, and AEM indicates capacity to offer integrated digital solutions, data analytics, and streamlined regulatory workflows as value-added services.

Mid-Mized Growth Revenue in the hundred-million range with 51-200 employees places Katalyst CRO between mid-market CROs and larger players, presenting a compelling target for mid-size pharma/biotech firms seeking flexible partnerships and faster deployment timelines.